Phase 2 PTSD Trial, Recruiting NCT07214415 Sponsor: Summit Hyperbarics and Wellness Condition: PTSD
Back to Ptsd

Phase 2 PTSD Trial, Recruiting

NCT07214415
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are at least 18 years old and no older than 75 years old.
  • You are a veteran.
  • You have been officially diagnosed by a qualified professional with a mild traumatic brain injury (mild TBI), PTSD, anxiety, or depression.
  • You are willing and able to read, understand, and sign a consent form, and can clearly express your own thoughts and feelings.
  • You have previously tried at least one therapy treatment for trauma or mental health, such as prolonged exposure therapy, EMDR, or cognitive behavioral therapy (CBT).
  • You have completed certain memory, thinking, and psychological assessments (confirm with trial site).
  • Your diagnosis significantly affects your ability to work, maintain relationships, or carry out daily activities.
  • If you are a woman who could become pregnant, or a man whose partner could become pregnant, you must agree to use an acceptable form of birth control throughout the study and for 30 days after the last treatment session.
  • You are on a stable dose of any current psychiatric medications (such as antidepressants, anti-anxiety, or mood-related medications).

Who may not be able to join:

  • You have a collapsed lung (pneumothorax) that has not been treated, or you have had one in the past.
  • You currently have a severe sinus infection or an upper respiratory infection (such as a heavy cold).
  • You have lung abnormalities that showed up on a chest X-ray but are not causing symptoms (confirm with trial site).
  • You have a high fever that cannot be controlled (above 39°C / 102.2°F).
  • You have had surgery on your chest or ears in the past.
  • You have a condition called congenital spherocytosis (an inherited red blood cell disorder).
  • You have any type of anemia or blood disorder.
  • You have a seizure or convulsion disorder.
  • You have a history of optic neuritis (eye nerve inflammation) or sudden vision loss.
  • You have a middle ear infection.
  • You have diabetes and use insulin to manage it.
  • You are currently pregnant or breastfeeding.
  • You currently use nicotine, substances, or have an addiction.
  • You have dangerously low blood sugar (acute hypoglycemia).
  • You have been diagnosed with COPD or emphysema.
  • You are currently experiencing coughing, congestion, vomiting, diarrhea, or have open wounds.
  • You have an active cancer diagnosis.
  • You are currently experiencing a manic, delusional, or psychotic episode.
  • You are currently having serious thoughts of suicide.
  • You have a severe or unstable physical health condition, or significant difficulties with thinking and memory.
  • You are unable to attend scheduled appointments or follow the study's procedures.
  • You have previously received hyperbaric oxygen therapy (HBOT) for any reason.
  • You are not a native or fluent English speaker.
  • You have had eye surgery, including laser eye treatment or surgery for a detached retina.
  • You have had surgery on your middle ear (such as eardrum repair or ear tube placement).
  • You are currently taking certain medications, including chemotherapy drugs, methotrexate, disulfiram (Antabuse), nitroglycerin, or certain antibiotics that may interact with this treatment (confirm specific medications with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Steven Wyman, MD, Summit Hyperbarics and Wellness

Phone: 208-813-9541

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Summit Hyperbarics and Wellness
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
15 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PTSD Checklist for DSM-5 (PCL-5); NeuroTrax; Patient Health Questionnaire-9 (PHQ-9); Generalized Anxiety Disorder 7-item scale (GAD-7); World Health Organization Quality of Life (WHOQOL-BREF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov